BELLUS Health is a biopharmaceutical development company advancing novel therapeutics for conditions with high unmet medical need. Its pipeline of projects includes BLU-5937 for chronic cough potentially best-in-class drug for multi billion dollar chronic cough market. BELLUS maintains a balanced portfolio in several other partnered clinical-stage drug development programs. President and CEO, Roberto Bellini leads a management team with a strong record of execution. TSX:BLU (Recent SP: $.38)

BELLUS Health Presentation August 2017

Perimeter Medical Imaging develops, patents, and commercializes advanced surgical imaging tools that allow surgeons, radiologists and pathologists to better assess microscopic tissue structures during surgical procedures. Perimeter’s Optical Tissue Imaging System (OTIS™) is the only solution that provides clinicians with an ultra-high resolution image of the entire surface of an excised tissue specimen, providing accurate information in real time, and enabling better surgical decisions and outcomes.

Liberty Silver Corp. is focused on exploring and developing mineral properties located in North America. The Company is led by an experienced, management team and board of directors with significant experience managing exploration, development and mining projects. Liberty has the right to earn a joint venture interest in the 10,020-acre Trinity Silver Project. The Trinity Silver Project, located in Pershing County, Nevada, is Liberty’s flagship project. Liberty recently announced that it has entered into the Letter of Intent to Acquire the Bunker Hill Mine Complex which is subject to due diligence and definitive documentation. CSE:LSL (Recent SP: $1.50)

Liberty Silver – Bunker Hill Presentation June 2017

Xebec is a gas generation, purification and filtration company that develops, designs and manufactures gas purification products and technology solutions for environmentally responsible applications in industry, transportation and the public sector. On May 24th, 2017 the company reported Q1 2017 revenues of $3.3M, gross profit of $1.4M and a positive EBITDA of $0.7M. Xebec currently has more than 9,000 units deployed worldwide to over 1,500 clients.  TSX.V: XBC (Recent SP: $0.39)

Xebec Presentation June 2017

Group RMC Corporation (RMC) invests in, sponsors, and is the General Partner in underappreciated income producing office properties in secondary US markets. It currently oversees approximately 9M SF, representing over $1bn in asset value, principally in the Midwest. RMC’s principals seek long-term co-investment partners, not ‘clients,’ as such, RMC only levies its charges up-front and only in the form of shares in the partnership. It does not charge ‘back end,’ ‘carry,’ or even management fees that hemorrhage returns on partners’ capital – a structure that is unique in both its low pricing and risk sharing. RMC has offices in Montreal, London & New York City. 

PreveCeutical is a health and wellness company focused on utilizing nature and science for the benefit of health conscious consumers. PreveCeutical’s lead product is the CellB9 supplement, which harnesses the effects of scorpion venom. The company is in the process of developing a pharmaceutical treatment around the venom to validate its health benefits. In addition, PreveCeutical is working on a cannabinoid delivery agent known as Sol-Gels, as well as conducting research on gene therapy treatments. PreveCeutical is currently involved in a RTO with Carrara Exploration. CSE: CAA (Recent SP: $0.22)

First Cobalt Corp is focused on building a diversified global portfolio of assets that are highly leveraged to the cobalt market. The economic background estimates global consumption for refined cobalt is set to reach 100 kt in 2017. While demand growth for most metals has stalled in recent years, cobalt demand continues to grow strongly, with some estimates indicating that its demand will grow at an average rate of approximately 5% per annum for the next ten years. TSX.V: FCC OTC: FTSSF 

 First Cobalt – Investor Presentation May 31 2017

HPQ Silicon Resources Inc is a TSX-V listed junior exploration company planning to become a vertically integrated and diversified High Value Silicon Metal (99.9+% Si), and Solar Grade Silicon Metal (99.999+% Si) producer. HPQ’s business model is focused on developing a disruptive High Purity and Solar Grade Silicon Metal manufacturing process (patent pending) and becoming a vertically – integrated High Value Silicon Metal and Solar Grade Silicon producer that can generate high yield returns and significant free cash flow within a relatively short time line. TSX.V: HPQ 

HPQ – Investor Presentation May 31, 2017

WE INVITE YOU TO ATTEND

5pm to 7pm

WEDNESDAY, May 31, 2017, Paul Benwell & Associates will host a cocktail presentation in the Penthouse Suite at 999 de Maisonneuve W. where the following companies will have the opportunity to present their story to the Montreal investment community.

First Cobalt Corp is focused on building a diversified global portfolio of assets that are highly leveraged to the cobalt market. The economic background estimates global consumption for refined cobalt is set to reach 100 kt in 2017. While demand growth for most metals has stalled in recent years, cobalt demand continues to grow strongly, with some estimates indicating that its demand will grow at an average rate of approximately 5% per annum for the next ten years. TSX.V: FCC OTC: FTSSF (Recent SP: $0.44)

HPQ Silicon Resources Inc is a TSX-V listed junior exploration company planning to become a vertically integrated and diversified High Value Silicon Metal (99.9+% Si), and Solar Grade Silicon Metal (99.999+% Si) producer. HPQ’s business model is focused on developing a disruptive High Purity and Solar Grade Silicon Metal manufacturing process (patent pending) and becoming a vertically – integrated High Value Silicon Metal and Solar Grade Silicon producer that can generate high yield returns and significant free cash flow within a relatively short time line. TSX.V: HPQ (Recent SP: $0.14)

United Hunter Oil & Gas Corp. is a Canadian based corporation with management very experienced in the oil and gas industry. United Hunter Oil & Gas Corp., through its wholly owned subsidiary, United Hunter Texas, LLC, (“UHT”) entered into an exclusive Option Agreement with Wilson Operating Company and certain other owners for the option to purchase 100% of the Vendors’ oil and gas interests in the Hull Silk Sikes 4,300’ Sand Unit (“HSS Unit”) and other rights in and related to the 4,300 foot sand zone, which is the same zone covered by the HSS Unit, in Archer County, Texas. TSX.V: UHO (Recent SP: $0.17)

To secure your place as an attendee or for more information please contact

Paul Benwell at paul@paulbenwell.com or 514-233-1036.

Sophy Cesar at scesar@paulbenwell.com 514-641-6897.

Please visit our page to see previous events. www.paulbenwell.com/5-a-7-events

WE INVITE YOU TO ATTEND

5pm to 7pm

WEDNESDAY, April 26, 2017, Paul Benwell & Associates will host a cocktail presentation in the Penthouse Suite at 999 de Maisonneuve W. where the following companies will have the opportunity to present their story to the Montreal investment community.

Symbility is a global leader in mobile solutions for the insurance industry creating world-class experiences that simplify business and improve lives. With a history in modernizing insurance claims solutions for the property and health industries, Symbility has established itself as a partner that puts security, efficiency and customer experience first. They recently announced revenue of $34.3M for 2016, a 29% increase over the previous year. With their three segments pushing industries forward, Symbility proves that change for the better is entirely possible.  Symbility PROPERTY™ brings smarter thinking to property insurance. Symbility HEALTH™ helps benefits professionals build their brands and businesses. Symbility INTERSECT delivers mobile and IoT product strategy, design thinking, and engineering excellence for businesses that want to get ahead. TSX.V: SY (Recent SP: $0.53)

Pediapharm is the first and only specialty pharmaceutical company in Canada that exclusively distributes and licenses, innovative medicines used to treat pathological conditions that mainly affect children from infancy to eighteen years of age. The company announced February 28, 2017, a 73% increase in revenue for Q3. The company’s primary objective is to help improve children’s health and quality of life; its partners can thus be assured of long-term commitment and unwavering integrity. Pediapharm’s unique business model and company values set it apart as Canada’s leading pediatric specialty pharmaceutical company. TSX.V: PDP (Recent SP: $0.28)

Wallbridge is establishing a pipeline of projects that will support sustainable production and revenue as well as organic growth through exploration and scalability. Wallbridge is currently preparing to develop its 100%-owned high-grade gold Fenelon Mine project in Quebec with a production decision targeted for Q2 2017. Wallbridge is also in discussions regarding several other advanced stage projects, which could become the Company’s next mines. These discussions benefit from the operating capabilities Wallbridge demonstrated by safely and efficiently mining the Broken Hammer deposit in Sudbury, which was completed in October 2015. TSX: WM (Recent SP: $0.11) 

To secure your place as an attendee or for more information please contact

Paul Benwell at paul@paulbenwell.com or 514-233-1036.

Sophy Cesar at scesar@paulbenwell.com 514-641-6897.

Carl McGill at carl@paulbenwell.com or 416-278-8406.

Please visit our page to see previous events. www.paulbenwell.com/5-a-7-events

Potash Ridge is a near term producer of premium fertilizer with world-class development assets in Utah and Quebec. Potash Ridge is a Canadian based exploration and development company with a unique opportunity to develop a mine and processing facility to produce sulphate of potash “SOP”. SOP is a premium priced, low-chloride potash fertilizer. Potash Ridge has a highly qualified and proven management team in place with significant financial, project management and operation experience and the ability to take projects into production. TSX: PRK 

Potash Ridge Investor Presentation Montreal March 2017

Cruz is actively engaged in acquiring and developing Cobalt Assets globally. Cruz currently has seven cobalt projects located in Canada, one in Idaho and now one in Montana. Cruz’s four separate Ontario cobalt prospects are all located in the vicinity of the city of Cobalt making Cruz one of the largest land holders in this emerging cobalt district. The goal of the company is to make Cruz the foremost cobalt project generator and developer on the TSX Venture Exchange. Management feels that cobalt is at the early stages of a significant bull market and we are pleased to be positioning Cruz at the forefront of this cycle. TSX.V: CUZ 

Cruz Cobalt Corp – Deck 2017 Montreal

Avalon Advanced Materials Inc. is a Canadian mineral development company specializing in niche market metals and minerals with growing demand in new technology. The Company has three advanced stage projects, all 100%-owned, providing investors with exposure to lithium, tin and indium, as well as rare earth elements, tantalum, niobium, and zirconium. Avalon is currently focusing on its Separation Rapids Lithium Project, Kenora, ON and its East Kemptville Tin-Indium Project, Yarmouth, NS. Social responsibility and environmental stewardship are corporate cornerstones. and Croptimal. TSX.V: AVL 

AVL Presentation 17 03 20